When administered correctly and under the supervision of a professional, ketamine can be a life-changing treatment for major depression. But following regulatory changes put in place during the COVID-19 pandemic that made telemedicine more accessible, the drug’s off-label, unsupervised use has skyrocketed despite limited data supporting the safety and efficacy of that practice.
Leave A Comment